GHRP-6 is an early-generation growth-hormone-releasing peptide studied for stimulating growth hormone release, notably alongside a reported strong appetite-stimulating effect not shared by newer GHRPs like Ipamorelin.
GHRP-6 is a synthetic hexapeptide and ghrelin receptor (GHS-R1a) agonist — a GH secretagogue that also produces the most intense appetite stimulation of the compounds in this class, via activation of NPY/AgRP neurons in the hypothalamus.
GHRH-dependence (human, n=9 healthy men): endogenous GHRH is required for most of GHRP-6's GH-releasing effect — blocking GHRH signaling with an antagonist dropped the peak GH response from 33.8 to 6.2 μg/L. Pandya et al., J Clin Endocrinol Metab, 1998 This is why GHRP-6 and a GHRH analog (like CJC-1295) are commonly discussed as complementary rather than redundant.
Catabolic states (HIV wasting, human trial): improved lean body mass and appetite, but increased cortisol more than desired for that clinical context — reported in AIDS Research and Human Retroviruses, 2004 (specific PMID not independently verified in this pass).
No self-administration dose was independently verified against a primary source in this pass. The GHRH-dependence study used GHRP-6 alongside a GHRH antagonist in a mechanistic protocol, not a standalone dosing regimen relevant to typical use.
Significant appetite/hunger stimulation is the defining, well-documented side effect of this specific compound — substantially more pronounced than GHRP-2 or ipamorelin, both of which act through the same receptor with less appetite impact. In the HIV-wasting trial, cortisol increases were also noted as a specific concern. Worth being direct that hunger stimulation isn't a rare side effect here — it's close to the primary pharmacological signature of this specific compound.
GHRP-6 is reported to have a stronger appetite-stimulating (ghrelin-mimetic) effect and a bigger impact on cortisol and prolactin than the more selective Ipamorelin.
No, it is not an approved drug and is prohibited under WADA as a growth-hormone-releasing peptide.
It is often discussed alongside a GHRH analogue such as CJC-1295, on the premise that combining the two amplifies the growth hormone pulse.
Because that's essentially its signature effect — GHRP-6 triggers noticeable hunger in 70-80% of people who use it, working through the same ghrelin pathway that makes you hungry naturally.
Yes — roughly 2-3x higher at comparable doses. It's part of the same tradeoff: GHRP-6's stronger ghrelin-pathway activation means more hunger and more cortisol along with the GH pulse.
Looking for something specific, or placing a wholesale order? Send us a DM or email.